Li D - Search Results

1

Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy.

Huang F, Li J, Wen X, Zhu B, Liu W, Wang J, Jiang H, Ding Y, Li D, Zhang X. Huang F, et al. Among authors: li d, li j. Sci Rep. 2022 Jun 10;12(1):9559. doi: 10.1038/s41598-022-13391-y. Sci Rep. 2022. PMID: 35688842 Free PMC article.

2

The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP.

Li JJ, Ding Y, Li DD, Peng RQ, Feng GK, Zeng YX, Zhu XF, Zhang XS. Li JJ, et al. Cancer Biol Ther. 2009 Oct;8(20):1914-21. doi: 10.4161/cbt.8.20.9439. Epub 2009 Oct 6. Cancer Biol Ther. 2009. PMID: 20009541 Free article.

3

Rhabdastrellic acid-A induced autophagy-associated cell death through blocking Akt pathway in human cancer cells.

Li DD, Guo JF, Huang JJ, Wang LL, Deng R, Liu JN, Feng GK, Xiao DJ, Deng SZ, Zhang XS, Zhu XF. Li DD, et al. PLoS One. 2010 Aug 17;5(8):e12176. doi: 10.1371/journal.pone.0012176. PLoS One. 2010. PMID: 20808909 Free PMC article.

4

Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells.

Wang Y, Peng RQ, Li DD, Ding Y, Wu XQ, Zeng YX, Zhu XF, Zhang XS. Wang Y, et al. Chin J Cancer. 2011 Oct;30(10):690-700. doi: 10.5732/cjc.011.10056. Chin J Cancer. 2011. PMID: 21959046 Free PMC article.

5

The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment.

Li DD, Sun T, Wu XQ, Chen SP, Deng R, Jiang S, Feng GK, Pan JX, Zhang XS, Zeng YX, Zhu XF. Li DD, et al. PLoS One. 2012;7(9):e45058. doi: 10.1371/journal.pone.0045058. Epub 2012 Sep 14. PLoS One. 2012. PMID: 23024792 Free PMC article.

6

Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced non-small cell lung cancer.

Li CH, Liu MY, Liu W, Li DD, Cai L. Li CH, et al. Asian Pac J Cancer Prev. 2014;15(2):731-6. doi: 10.7314/apjcp.2014.15.2.731. Asian Pac J Cancer Prev. 2014. PMID: 24568487 Free article. Clinical Trial.

7

Efficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma.

Guo YQ, Ding Y, Li DD, Li JJ, Peng RQ, Wen XZ, Zhang X, Zhang XS. Guo YQ, et al. Med Oncol. 2015 Sep;32(9):234. doi: 10.1007/s12032-015-0679-7. Epub 2015 Aug 23. Med Oncol. 2015. PMID: 26298530 Clinical Trial.

8

Reactive oxygen species mediate oxaliplatin-induced epithelial-mesenchymal transition and invasive potential in colon cancer.

Jiao L, Li DD, Yang CL, Peng RQ, Guo YQ, Zhang XS, Zhu XF. Jiao L, et al. Tumour Biol. 2016 Jun;37(6):8413-23. doi: 10.1007/s13277-015-4736-9. Epub 2016 Jan 5. Tumour Biol. 2016. PMID: 26733168

9

Safety of immune checkpoint inhibitors in Chinese patients with melanoma.

Wen X, Wang Y, Ding Y, Li D, Li J, Guo Y, Peng R, Zhao J, Zhang X, Zhang XS. Wen X, et al. Among authors: li d, li j. Melanoma Res. 2016 Jun;26(3):284-9. doi: 10.1097/CMR.0000000000000256. Melanoma Res. 2016. PMID: 27116334

10

Late-stage inhibition of autophagy enhances calreticulin surface exposure.

Li DD, Xie B, Wu XJ, Li JJ, Ding Y, Wen XZ, Zhang X, Zhu SG, Liu W, Zhang XS, Peng RQ. Li DD, et al. Oncotarget. 2016 Dec 6;7(49):80842-80854. doi: 10.18632/oncotarget.13099. Oncotarget. 2016. PMID: 27825129 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,863 results

Search Page

Filters